Why peer review matters: insights from the scientific community

Cell & Gene Therapy Insights 2025; 11(1), 235–241

DOI: 10.18609/cgti.2025.028

Published: 28 February
Expert Roundtable
Atul Goyal, Alexis Cockroft, Panteli Theocharous, Vijesh Kumar, Hemant Dhamne



The panel (from left to right): Atul Goyal PhD, Senior Scientist, Pfizer; Alexis Cockroft PhD, Director and Regulatory Consultant, Lex Regulatory Ltd; Panteli Theocharous PhD FRCPath, Chief Therapeutics Officer and Head of Medical and Scientific Affairs, Garuda Therapeutics; Vijesh Kumar PhD, Lead Scientist, Spark Therapeutics; Hemant Dhamne PhD, Associate Director, Process Development, Autolus Ltd.

Despite their invaluable expertise and thoughtful feedback, peer reviewers often go unrecognized and are not formally acknowledged in publications. This raises important questions: what makes participating in peer review worthwhile, and can this process be improved? Jokūbas Leikauskas (Editor, BioInsights) speaks to a panel of experts about their experiences participating in the BioInsights peer review process, the value to authors of constructive feedback, and the importance of independent peer review in upholding the integrity of scientific literature.